Risk factors

Champions Oncology (CSBR) risk factors

Item 1A of every Champions Oncology, Inc. 10-K on file, and what changed from one year to the next.

Open CSBR in Gloomberb →
  • FY2026 10-K risk factors

    31 risks, 2 reworded since the prior year. Results deteriorated from $4.7 million net income to $1.2 million net loss, with accumulated deficit increasing to $81.1 million.

    Filed Jul 27, 2026
  • FY2025 10-K risk factors

    31 risks. Champions Oncology relies primarily on research services and a single Rockville laboratory facility containing its mouse colony and TumorBank. The company faces high competition, customer study cancellations, and operational risks tied to management in Israel.

    Filed Jul 23, 2025